StonvexLoading…
StonvexStonvexStonvexCore line items from NMM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.34B | $1.33B | $1.31B | $1.21B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $285.33M | $367.31M | $433.64M | $579.25M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $5.93B | $5.67B | $5.15B | $4.90B |
Total Liabilities | $2.59B | $2.57B | $2.38B | $2.55B |
Cash & Equivalents | $402.78M | $270.17M | $240.38M | $157.81M |
Free Cash Flow OCF − CapEx | $281.04M | $-263.55M | $377.42M | $72.56M |
Shares Outstanding | Not available | Not available | Not available | Not available |